| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.35B | 13.11B | 21.01B | 24.42B | 43.64B |
| Gross Profit | -13.07B | -7.23B | 161.62M | 3.36B | 12.05B |
| EBITDA | -16.92B | -9.88B | -2.47B | -7.62B | 10.12B |
| Net Income | -205.70M | -16.61B | -4.51B | -9.86B | 3.26B |
Balance Sheet | |||||
| Total Assets | 64.90B | 88.54B | 121.11B | 149.93B | 198.39B |
| Cash, Cash Equivalents and Short-Term Investments | 1.08B | 840.48M | 1.73B | 2.74B | 14.72B |
| Total Debt | 33.24B | 51.66B | 49.96B | 50.28B | 56.63B |
| Total Liabilities | 72.73B | 96.41B | 110.45B | 130.02B | 155.74B |
| Stockholders Equity | -15.66B | -16.42B | 633.38M | 5.75B | 19.26B |
Cash Flow | |||||
| Free Cash Flow | 961.61M | 1.33B | 4.22B | -546.33M | 78.90M |
| Operating Cash Flow | 963.78M | 1.34B | 4.25B | -510.64M | 128.97M |
| Investing Cash Flow | 269.90M | -467.37M | 56.45M | 1.57B | -22.32B |
| Financing Cash Flow | -1.66B | -1.76B | -5.31B | -13.05B | 3.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
41 Neutral | HK$113.39M | -0.54 | ― | ― | -73.46% | 95.45% | |
41 Neutral | HK$191.39M | -0.04 | -34.31% | ― | -69.02% | -41.71% | |
40 Underperform | HK$74.25M | >-0.01 | 77.11% | ― | -70.62% | -155.99% | |
40 Underperform | HK$86.19M | -0.02 | -1347.47% | ― | -61.86% | 17.85% | |
40 Underperform | HK$213.53M | <0.01 | -1029.68% | ― | -30.04% | ― | |
40 Underperform | HK$151.51M | -0.01 | 55.65% | ― | -75.81% | 16.54% |